{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:25:51Z","timestamp":1760059551612,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea (NRF)","award":["RS-2022-NR070216"],"award-info":[{"award-number":["RS-2022-NR070216"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: MicroRNAs are emerging as valuable diagnostic markers for various diseases, including papillary thyroid carcinoma (PTC). However, there is limited research on circulating miRNA expression in papillary thyroid microcarcinoma (PTMC). Therefore, we conducted a study to explore whether plasma-derived miRNAs can distinguish PTMC from benign nodules or predict aggressiveness. Methods: A total of 150 patients who underwent thyroidectomy from January 2013 to July 2021 were enrolled in this study. Patients were divided into three groups: benign, low-risk PTMC, and advanced PTMC. Nine patients from each group were selected for microarray analysis for plasma miRNAs. Six miRNAs were selected for comparison of expression levels using TaqMan assay. The ROC curve was utilized to evaluate the diagnostic and aggressiveness value of the miRNAs. Results: From the microarray analysis, miR-455-3p and miR-548ac were identified as miRNAs that can significantly differentiate between benign nodules and PTMC. A combination of six miRNAs (miR-455-3p, miR-548ac., miR-221, miR-222, miR-146a. miR-146b) rather than individual miRNAs had the highest AUC (0.857), sensitivity (0.867), and specificity (0.800) in differentiating benign and PTMC. In microarray analysis, no significant miRNAs were observed to distinguish between low-risk group and aggressive PTMC. However, in the six-miRNA combination, it was possible to distinguish low-risk PTMC from aggressive PTMC with an AUC of 0.763, sensitivity of 0.739, and the specificity of 0.727. Conclusions: A combination of six miRNAs presents the possibility of distinguishing between benign and PTMC and low-risk and aggressive PTMC with an acceptable AUC, sensitivity, and specificity.<\/jats:p>","DOI":"10.3390\/cancers17132079","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T03:39:26Z","timestamp":1750649966000},"page":"2079","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and Evaluation of Aggressiveness Using Circulating Plasma miRNAs in Papillary Thyroid Microcarcinoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-0421","authenticated-orcid":false,"given":"Jiwon","family":"Jang","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3608-765X","authenticated-orcid":false,"given":"Ji Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-0648","authenticated-orcid":false,"given":"Sung-Chan","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-il","family":"Cheon","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-8859","authenticated-orcid":false,"given":"Mijin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-8357","authenticated-orcid":false,"given":"Sang Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-6688","authenticated-orcid":false,"given":"Byung-Joo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, Good-Gang-An Hospital, Busan 48265, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Orlandella, F.M., Imperlini, E., Pane, K., Luciano, N., Braile, M., De Stefano, A.E., Iervolino, P.L.C., Ruocco, A., Orr\u00f9, S., and Franzese, M. (2024). miR-331-5p affects motility of thyroid cancer cell lines and regulates BID expression. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030658"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid Cancer: A Review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"ref_3","unstructured":"National Cancer Institute (2023). SEER Cancer Statistics Review [Internet], National Cancer Institute. Available online: https:\/\/seer.cancer.gov\/statfacts\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/SLA.0000000000003580","article-title":"The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults","volume":"271","author":"Patel","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/trp.trp_10_22","article-title":"Overdiagnosis and overtreatment of papillary thyroid carcinoma: A multidisciplinary review","volume":"18","author":"Oharram","year":"2021","journal-title":"Thyroid Res. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101630","DOI":"10.1016\/j.beem.2022.101630","article-title":"Active surveillance of low-risk papillary thyroid microcarcinoma","volume":"37","author":"Sugitani","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: Small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"109995","DOI":"10.1016\/j.cellsig.2021.109995","article-title":"Micro-RNA: The darkhorse of cancer","volume":"83","author":"Budakoti","year":"2021","journal-title":"Cell Signal"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1662","DOI":"10.1002\/wrna.1662","article-title":"microRNA-based diagnostic and therapeutic applications in cancer medicine","volume":"12","author":"Sempere","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_11","first-page":"2144","article-title":"Micro-RNAs signatures in papillary thyroid carcinoma","volume":"25","author":"Mastronikolis","year":"2020","journal-title":"J. BUON"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/CBM-2012-0273","article-title":"The value of miRNA in diagnosing thyroid cancer: A systematic review","volume":"11","author":"Lodewijk","year":"2012","journal-title":"Cancer Biomark."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Toraih, E.A., Fawzy, M.S., Ning, B., Zerfaoui, M., Errami, Y., Ruiz, E.M., Hussein, M.H., Haidari, M., Bratton, M., and Tortelote, G.G. (2022). A miRNA-based prognostic model to trace thyroid cancer recurrence. Cancers, 14.","DOI":"10.3390\/cancers14174128"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3892\/or.2017.5994","article-title":"miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma","volume":"38","author":"Qiu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cca.2018.06.012","article-title":"MiRNA-221\/222 in thyroid cancer: A meta-analysis","volume":"484","author":"Liang","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shen, H., Lin, Z., Shi, H., Wu, L., Ma, B., Li, H., Yin, B., Tang, J., Yu, H., and Yin, X. (2020). MiR-221\/222 promote migration and invasion, and inhibit autophagy and apoptosis by modulating ATG10 in aggressive papillary thyroid carcinoma. 3 Biotech, 10.","DOI":"10.1007\/s13205-020-02326-x"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.oraloncology.2014.10.006","article-title":"Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer","volume":"51","author":"Lee","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Liu, Y., Geng, H., Liu, X., Cao, M., and Zhang, X. (2021). A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251676"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Papaioannou, M., Chorti, A.G., Chatzikyriakidou, A., Giannoulis, K., Bakkar, S., and Papavramidis, T.S. (2021). MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.755097"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ruiz-Pozo, V.A., Cadena-Ullauri, S., Guevara-Ram\u00edrez, P., Paz-Cruz, E., Tamayo-Trujillo, R., and Zambrano, A.K. (2023). Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1139362"},{"key":"ref_22","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., Dungan, K., Grossman, A., Hershman, J.M., Kaltsas, G., Koch, C., and Kopp, P. (2023). Fine-NeedleAspirationoftheThyroidGland. Endotext, MDText.com, Inc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3803\/EnM.2024.1938","article-title":"A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules","volume":"39","author":"Lee","year":"2024","journal-title":"Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ho, P.T.B., Clark, I.M., and Le, L.T.T. (2022). MicroRNA-Based Diagnosis and Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137167"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40291-016-0221-4","article-title":"Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects","volume":"20","author":"Backes","year":"2016","journal-title":"Mol. Diagn. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/SLA.0b013e318265bd6f","article-title":"Plasma miR-21: A potential diagnostic marker of colorectal cancer","volume":"256","author":"Kanaan","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Qi, P., Cheng, S., Wang, H., Li, N., Chen, Y., and Gao, C. (2011). Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028486"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Batra, J.S., Girdhani, S., and Hlatky, L. (2014). A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential. J. Biomark., 2014.","DOI":"10.1155\/2014\/321680"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7150\/jca.12351","article-title":"Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers","volume":"7","author":"Chen","year":"2016","journal-title":"J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0033-1341516","article-title":"Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type2 diabetes","volume":"121","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chou, C.K., Liu, R.T., and Kang, H.Y. (2017). MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030636"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1089\/thy.2015.0193","article-title":"MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review","volume":"25","author":"Han","year":"2015","journal-title":"Thyroid"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kondrotiene, A., Dauksa, A., Pamedytyte, D., Kazokaite, M., Zvirbliene, A., Dauksiene, D., Simanaviciene, V., Klimaite, R., Golubickaite, I., and Stakaitis, R. (2021). Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features. Diagnostics, 11.","DOI":"10.3390\/diagnostics11030418"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.21873\/invivo.12866","article-title":"Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review","volume":"36","author":"Geropoulos","year":"2022","journal-title":"In Vivo"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e23907","DOI":"10.1002\/jcla.23907","article-title":"Aberrant expression of five miRNAs in papillary thyroid carcinomas","volume":"35","author":"Qiao","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1203208","article-title":"Molecular testing for the indeterminate thyroid nodule","volume":"367","author":"Alexander","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: A prospective multicenter study","volume":"5","author":"Steward","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Markopoulos, G.S., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K.B., and Kolettas, E. (2018). Roles of NF-\u03baB signaling in the regulation of miRNAs impacting on inflammation in cancer. Biomedicines, 6.","DOI":"10.3390\/biomedicines6020040"},{"key":"ref_40","first-page":"3611","article-title":"Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma","volume":"40","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11586","DOI":"10.3390\/molecules190811586","article-title":"Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma","volume":"19","author":"Peng","year":"2014","journal-title":"Molecules"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"D\u2019Amico, G., Santonocito, R., Grech, G., Graceffa, G., Cipolla, C., Scalia, F., Raccosta, S., Manno, M., Conwayde Macario, E., and Macario, A.J.L. (2024). MiRNAs in Extracellular Vesicles as Biomarkers in Plasma of Papillary Thyroid Cancer Patients: A Proof-of-Concept Study. Biology, 13.","DOI":"10.3390\/biology13090743"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Toraih, E.A., Elshazli, R.M., Trinh, L.N., Hussein, M.H., Attia, A.A., Ruiz, E.M.L., Zerfaoui, M., Fawzy, M.S., and Kandil, E. (2021). Diagnostic and prognostic performance of liquid biopsy-derived exosomal microRNAs in thyroid cancer patients: A systematic review and meta-analysis. Cancers, 13.","DOI":"10.3390\/cancers13174295"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/13\/2079\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:56:12Z","timestamp":1760032572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/13\/2079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":43,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cancers17132079"],"URL":"https:\/\/doi.org\/10.3390\/cancers17132079","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,6,21]]}}}